Literature DB >> 19669334

Prevalence and risk factors for hepatitis C infection in rural north Vietnam.

Van Thi Thuy Nguyen1, Mary-Louise McLaws, Gregory J Dore.   

Abstract

BACKGROUND: In Vietnam, the prevalence of hepatitis C virus (HCV) infection among injecting drug users and patients with liver disease is known to be high, yet the magnitude of HCV in the general population, particularly in rural areas, has not been clearly estimated. A community-based study was used to determine the prevalence of HCV infection in a rural population of north Vietnam and explore risk factors associated with HCV acquisition.
METHOD: A community-based viral hepatitis seroprevalence study using a multistage sampling method to recruit participants was undertaken. The study population size (n = 837) had been determined on the basis of estimated hepatitis B virus (HBV) prevalence. Information on demography and potential risk factors were obtained using face-to-face interviews, and all selected participants were tested for anti-HCV antibody.
RESULTS: HCV prevalence in the study population was 1.0% (95% CI: 0.4%-1.9%). Hospital admission (adjusted odds ratio [AOR]: 7.19; 95% CI: 1.59-32.53; P = .01) and having tattoos (AOR: 13.37: 95% CI: 1.86-96.15; P = .01) were independent predictors of HCV infection, and farmers were less likely to have HCV infection than those in other occupations (AOR: 0.19; 95% CI: 0.04-0.84; P = .02).
CONCLUSION: The prevalence of HCV infection is low in the general rural population in northern Vietnam. An association between HCV infection and hospital admission and tattoos indicate a need to improve the standards of infection control in healthcare and other settings in this region.

Entities:  

Year:  2007        PMID: 19669334      PMCID: PMC2716832          DOI: 10.1007/s12072-007-9008-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  29 in total

1.  Nosocomial transmission of HCV in the liver unit of a tertiary care center.

Authors:  Xavier Forns; Eva Martínez-Bauer; Anna Feliu; Montserrat García-Retortillo; Marta Martín; Eugeni Gay; Miquel Navasa; Jose Maria Sánchez-Tapias; Miquel Bruguera; Juan Rodés
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

2.  Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.

Authors:  S Kakumu; K Sato; T Morishita; K A Trinh; H B Nguyen; V D Banh; H C Do; H P Nguyen; V T Nguyen; T T Le; N Yamamoto; H Nakao; S Isomura
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

3.  Community-based seroepidemiological survey of HCV infection in Catalonia, Spain.

Authors:  A Domínguez; M Bruguera; J Vidal; P Plans; L Salleras
Journal:  J Med Virol       Date:  2001-12       Impact factor: 2.327

4.  Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group.

Authors:  A Mele; M E Tosti; A Marzolini; A Moiraghi; P Ragni; G Gallo; E Balocchini; F Santonastasi; T Stroffolini
Journal:  J Viral Hepat       Date:  2000-01       Impact factor: 3.728

Review 5.  Hepatitis C: an epidemiological review.

Authors:  M I Memon; M A Memon
Journal:  J Viral Hepat       Date:  2002-03       Impact factor: 3.728

Review 6.  Epidemiology of hepatitis C virus infection in Australia.

Authors:  Gregory J Dore; Matthew Law; Margaret MacDonald; John M Kaldor
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

7.  Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.

Authors:  Pipat Luksamijarulkul; Nantaporn Thammata; Dusit Sujirarat; Mujarin Tiloklurs
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-03       Impact factor: 0.267

8.  Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission.

Authors:  Rosa Di Stefano; Tommaso Stroffolini; Donatella Ferraro; Antonella Usticano; Lilli Mario Valenza; Luigi Montalbano; Giuseppina Pomara; Antonio Craxì
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

9.  Highly endemic hepatitis B infection in rural Vietnam.

Authors:  Van Thi-Thuy Nguyen; Mary-Louise McLaws; Gregory J Dore
Journal:  J Gastroenterol Hepatol       Date:  2007-07-20       Impact factor: 4.029

10.  Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam.

Authors:  S Nakata; P Song; D D Duc; X Q Nguyen; K Murata; F Tsuda; H Okamoto
Journal:  J Gastroenterol Hepatol       Date:  1994 Jul-Aug       Impact factor: 4.029

View more
  17 in total

1.  Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.

Authors:  Nghia H Nguyen; Philip Vutien; Huy N Trinh; Ruel T Garcia; Long H Nguyen; Huy A Nguyen; Khanh K Nguyen; Mindie H Nguyen
Journal:  Hepatol Int       Date:  2010-04-09       Impact factor: 6.047

2.  Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study.

Authors:  Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Linh Pham Van; Hung Nguyen Van; Hoi Nguyen Thanh
Journal:  Biomed Res Int       Date:  2022-05-06       Impact factor: 3.246

3.  The genetic diversity and evolutionary history of hepatitis C virus in Vietnam.

Authors:  Chunhua Li; Manqiong Yuan; Ling Lu; Teng Lu; Wenjie Xia; Van H Pham; An X D Vo; Mindie H Nguyen; Kenji Abe
Journal:  Virology       Date:  2014-09-03       Impact factor: 3.616

Review 4.  Drug Abuse, HIV, and HCV in Asian Countries.

Authors:  Yih-Ing Hser; Di Liang; Yu-Ching Lan; Balasingam Kasinather Vicknasingam; Amit Chakrabarti
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-21       Impact factor: 4.147

5.  Hepatitis C virus seroprevalence in the general female population from 8 countries.

Authors:  Paloma Quesada; Denise Whitby; Yolanda Benavente; Wendell Miley; Nazzarena Labo; Saibua Chichareon; Nguyen Trong; Hai-Rim Shin; Pham Thi Hoang Anh; Jaiyeola Thomas; Elena Matos; Rolando Herrero; Nubia Muñoz; Monica Molano; Silvia Franceschi; Silvia de Sanjosé
Journal:  J Clin Virol       Date:  2015-05-12       Impact factor: 3.168

6.  Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus.

Authors:  Patrick Nadol; Siobhan O'connor; Hao Duong; Linh-Vi N Le; Pham Hong Thang; Tran Hong Tram; Hoang Thi Thanh Ha; Michelle S Mcconnell; Jeff Partridge; John Kaldor; Matthew Law; Tuan Anh Nguyen
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.

Authors:  Antony P Black; Keooudomphone Vilivong; Phonethipsavanh Nouanthong; Chanthasone Souvannaso; Judith M Hübschen; Claude P Muller
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

Review 8.  Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam.

Authors:  Son Huy Do
Journal:  Euroasian J Hepatogastroenterol       Date:  2015-01-06

9.  Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants.

Authors:  Linda Dunford; Michael J Carr; Jonathan Dean; Allison Waters; Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Jeff Connell; Suzie Coughlan; Hien Tran Nguyen; William W Hall; Lan Anh Nguyen Thi
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

10.  Factors Associated with Hepatitis C Knowledge Before and After an Educational Intervention among Vietnamese Americans.

Authors:  Sunmin Lee; Shumenghui Zhai; Guo Yolanda Zhang; Xiang S Ma; Xiaoxiao Lu; Yin Tan; Philip Siu; Brenda Seals; Grace X Ma
Journal:  Clin Med Insights Gastroenterol       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.